Virology

Genomic evolution of the Coronaviridae family.  570:123-133. 2022

Zika virus NS5 nuclear accumulation is protective of protein degradation and is required for viral RNA replication.  541:124-135. 2020

Structural characterization and biological function of bivalent binding of CD2AP to intrinsically disordered domain of chikungunya virus nsP3 protein.  537:130-142. 2019

Lack of nsP2-specific nuclear functions attenuates chikungunya virus replication both in vitro and in vivo.  534:14-24. 2019

A novel ejection protein from bacteriophage 80α that promotes lytic growth.  525:237-247. 2018

Fc-gamma receptor IIA and IIIA variants in two African cohorts: Lack of consistent impact on heterosexual HIV acquisition, viral control, and disease progression.  525:132-142. 2018

Characterization of apolipoprotein C1 in hepatitis C virus infection and morphogenesis.  524:1-9. 2018

Human cytomegalovirus-infected cells release extracellular vesicles that carry viral surface proteins.  524:97-105. 2018

Regulatory CD4 T cells inhibit HIV-1 expression of other CD4 T cell subsets via interactions with cell surface regulatory proteins.  516:21-29. 2018

Pathogenicity testing of influenza candidate vaccine viruses in the ferret model.  511:135-141. 2017

Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.  508:164-169. 2017

Targeted mutagenesis of the P22 portal protein reveals the mechanism of signal transmission during DNA packaging.  505:127-138. 2017

CD4 regulatory T cells augment HIV-1 expression of polarized M1 and M2 monocyte derived macrophages.  504:79-87. 2017

A novel cell-based assay to measure activity of Venezuelan equine encephalitis virus nsP2 protease.  496:77-89. 2016

A cationic liposome-DNA complexes adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of pre-pandemic influenza A (H5N1) vaccine in ferrets.  492:197-203. 2016

Adenoviral vectors elicit humoral immunity against variable loop 2 of clade C HIV-1 gp120 via "Antigen Capsid-Incorporation" strategy.  487:75-84. 2016

Both RIG-I and MDA5 detect alphavirus replication in concentration-dependent mode.  487:230-241. 2016

RNAP II processivity is a limiting step for HIV-1 transcription independent of orientation to and activity of endogenous neighboring promoters.  486:7-14. 2015

Diverse antigenic site targeting of influenza hemagglutinin in the murine antibody recall response to A(H1N1)pdm09 virus.  485:252-262. 2015

Oseltamivir inhibits influenza virus replication and transmission following ocular-only aerosol inoculation of ferrets.  484:305-312. 2015

Comparison of traditional intranasal and aerosol inhalation inoculation of mice with influenza A viruses.  481:107-112. 2015

T cell exhaustion during persistent viral infections.  479-480:180-193. 2015

Assessment of transmission, pathogenesis and adaptation of H2 subtype influenza viruses in ferrets.  477:61-71. 2015

Dynamics of viremia in primary HIV-1 infection in Africans: Insights from analyses of host and viral correlates.  449:254-262. 2014

Diversity of the murine antibody response targeting influenza A(H1N1pdm09) hemagglutinin.  458-459:114-124. 2014

Effect of receptor binding specificity on the immunogenicity and protective efficacy of influenza virus A H1 vaccines.  464-465:156-165. 2014

Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus.  454-455:169-175. 2014

Low antibody-dependent cellular cytotoxicity responses in Zambians prior to HIV-1 intrasubtype C superinfection.  462-463:295-298. 2014

Retargeting of gene expression using endothelium specific hexon modified adenoviral vector.  447:312-325. 2013

φ29 Scaffolding and connector structure-function relationship studied by trans-complementation.  444:355-362. 2013

Simvastatin and oseltamivir combination therapy does not improve the effectiveness of oseltamivir alone following highly pathogenic avian H5N1 influenza virus infection in mice.  439:42-46. 2013

Kinetics of viral replication and induction of host responses in ferrets differs between ocular and intranasal routes of inoculation.  438:56-60. 2013

Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones.  436:33-48. 2013

Modulation of hepatitis C virus RNA abundance and virus release by dispersion of processing bodies and enrichment of stress granules.  435:472-484. 2013

Anti-viral CD8 T cells and the cytokines that they love.  435:157-169. 2013

Assembly of bacteriophage 80α capsids in a Staphylococcus aureus expression system.  434:242-250. 2012

Pirates of the Caudovirales.  434:210-221. 2012

Human cytomegalovirus infection of THP-1 derived macrophages reveals strain-specific regulation of actin dynamics.  433:64-72. 2012

The roles of SaPI1 proteins gp7 (CpmA) and gp6 (CpmB) in capsid size determination and helper phage interference.  432:277-282. 2012

A multimeric L2 vaccine for prevention of animal papillomavirus infections.  420:43-50. 2011

Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitors.  415:56-68. 2011

Multiple genes contribute to the virulent phenotype observed in ferrets of an H5N1 influenza virus isolated from Thailand in 2004.  413:226-230. 2011

Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses.  413:139-147. 2011

Mechanism of translation initiation by Dicistroviridae IGR IRESs.  411:355-361. 2011

Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC.  408:1-13. 2010

An adenoviral vector expressing human adenovirus 5 and 3 fiber proteins for targeting heterogeneous cell populations.  407:196-205. 2010

Characterization of entry and infection of monocytic THP-1 cells by Kaposi's sarcoma associated herpesvirus (KSHV): role of heparan sulfate, DC-SIGN, integrins and signaling..  406:103-116. 2010

Erratum to Alteration of lipid metabolism in cells infected with human cytomegalovirus [Virology 404, (2010), 71-77].  406:164. 2010

Alteration of lipid metabolism in cells infected with human cytomegalovirus.  404:71-77. 2010

Efficient, trans-complementing packaging systems for chimeric, pseudoinfectious dengue 2/yellow fever viruses.  400:8-17. 2010

Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1.  396:339-348. 2010

Effective activation alleviates the replication block of CCR5-tropic HIV-1 in chimpanzee CD4+ lymphocytes.  394:109-118. 2009

In vitro incorporation of the phage Phi29 connector complex.  394:149-153. 2009

Kaposi sarcoma-associated herpes virus (KSHV) G protein-coupled receptor (vGPCR) activates the ORF50 lytic switch promoter: a potential positive feedback loop for sustained ORF50 gene expression..  392:34-51. 2009

The 5′UTR-specific mutation in VEEV TC-83 genome has a strong effect on RNA replication and subgenomic RNA synthesis, but not on translation of the encoded proteins.  387:211-221. 2009

Functional domains of the bacteriophage P2 scaffolding protein: Identification of residues involved in assembly and protease activity.  384:144-150. 2009

FOXP3 inhibits HIV-1 infection of CD4 T-cells via inhibition of LTR transcriptional activity.  381:161-167. 2008

Repression of human cytomegalovirus major immediate early gene expression by the cellular transcription factor CCAAT displacement protein.  378:214-225. 2008

A fusion protein of HCMV IE1 exon4 and IE2 exon5 stimulates potent cellular immunity in an MVA vaccine vector.  377:379-390. 2008

IRES-dependent replication of Venezuelan equine encephalitis virus makes it highly attenuated and incapable of replicating in mosquito cells.  377:160-169. 2008

The SARS-CoV ferret model in an infection-challenge study.  374:151-163. 2008

Incorporation of scaffolding protein gpO in bacteriophages P2 and P4.  370:352-361. 2008

Alpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infection.  367:307-323. 2007

Multiple immunizations with adenovirus and MVA vectors improve CD8⁺ T cell functionality and mucosal homing.  367:156-167. 2007

Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins.  366:212-225. 2007

Variola virus topoisomerase: DNA cleavage specificity and distribution of sites in Poxvirus genomes.  365:60-69. 2007

Phylogenetic analysis of WNV in North American blood donors during the 2003-2004 epidemic seasons.  363:220-228. 2007

Adaptation of Venezuelan equine encephalitis virus lacking 51-nt conserved sequence element to replication in mammalian and mosquito cells.  362:475-487. 2007

Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins.  360:218-234. 2007

Adeno-associated virus induces apoptosis during coinfection with adenovirus.  358:391-401. 2007

Kaposi's sarcoma herpesvirus C-terminal LANA concentrates at pericentromeric and peri-telomeric regions of a subset of mitotic chromosomes.  357:149-157. 2007

The G490E mutation in reverse transcriptase does not impact tRNA primer selection by HIV-1 with altered PBS and A-loop.  352:380-389. 2006

Production and characterization of vaccines based on flaviviruses defective in replication.  351:432-443. 2006

Evaluation of replicative capacity and genetic stability of West Nile virus replicons using highly efficient packaging cell lines.  351:196-209. 2006

An adenovirus serotype 5 vector with fibers derived from ovine atadenovirus demonstrates CAR-independent tropism and unique biodistribution in mice.  350:103-115. 2006

Assembly of bacteriophage P2 and P4 procapsids with internal scaffolding protein.  348:133-140. 2006

The efficient packaging of Venezuelan equine encephalitis virus-specific RNAs into viral particles is determined by nsP1-3 synthesis.  344:315-327. 2006

The γc-cytokine regulated transcription factor, STAT5, increases HIV-1 production in primary CD4 T cells.  344:283-291. 2006

Genetic analysis of the SARS-coronavirus spike glycoprotein functional domains involved in cell-surface expression and cell-to-cell fusion..  341:215-230. 2005

Heterologous RNA replication enhancer stimulates in vitro RNA synthesis and template-switching by the carmovirus, but not by the tombusvirus, RNA-dependent RNA polymerase: Implication for modular evolution of RNA viruses.  341:107-121. 2005

Virulence differences between monkeypox virus isolates from West Africa and the Congo basin.  340:46-63. 2005

Enhanced functional recovery from spinal cord injury following intrathecal or intramuscular administration of poliovirus replicons encoding IL-10.  336:173-183. 2005

Murine leukemia virus with a primer-binding site complementary to tRNA ^Lys,3 adapts to select new tRNAs for replication following extended in vitro culture.  333:337-348. 2005

Amphotericin-B-mediated reactivation of latent HIV-1 infection.  331:106-116. 2005

Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site.  330:221-232. 2004

HPV-18 confers resistance to TNF-α in organotypic cultures of human keratinocytes.  328:233-243. 2004

Nuclear localization of Vpr is crucial for the efficient replication of HIV-1 in primary CD4 ⁺ T cells.  327:249-261. 2004

Transport across a polarized monolayer of Caco-2 cells by transferrin receptor-mediated adenovirus transcytosis.  325:116-128. 2004

Analysis of murine leukemia virus replication complemented by yeast tRNA^Phe reveals inherent preferences for the tRNA primer selected for reverse transcription.  324:430-438. 2004

An adenovirus vector with a chimeric fiber derived from canine adenovirus type 2 displays novel tropism.  324:103-116. 2004

Overexpression of octamer transcription factors 1 or 2 alone has no effect on HIV-1 transcription in primary human CD4 T cells.  321:323-331. 2004

KSHV LANA1 binds DNA as an oligomer and residues N-terminal to the oligomerization domain are essential for DNA binding, replication, and episome persistence.  319:225-236. 2004

The genomic sequence of ectromelia virus, the causative agent of mousepox.  317:165-186. 2003

Immunogenicity in pig-tailed macaques of poliovirus replicons expressing HIV-1 and SIV antigens and protection against SHIV-89.6P disease.  315:425-437. 2003

Enterovirus 71 contains a type I IRES element that functions when eukaryotic initiation factor eIF4G is cleaved.  315:259-266. 2003

CD154-CD40-induced reactivation of latent HIV-1 infection.  314:261-270. 2003

Cleavage leads to expansion of bacteriophage P4 procapsids in vitro.  314:1-8. 2003

Gene expression in the muscle and central nervous system following intramuscular inoculation of encapsidated or naked poliovirus replicons.  314:45-61. 2003

Yeast tRNA^Phe expressed in human cells can be selected by HIV-1 for use as a reverse transcription primer.  313:354-363. 2003

A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism.  309:282-293. 2003

Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine.  308:270-278. 2003

Control of lymphocytic choriomeningitis virus infection in granzyme B deficient mice.  305:1-9. 2003

Evaluation of a genetically modified reassortant H5N1 influenza a virus vaccine candidate generated by plasmid-based reverse genetics.  305:192-200. 2003

Equivalent immunogenicity of the highly attenuated poxvirus-based ALVAC-SIV and NYVAC-SIV vaccine candidates in SIVmac251-infected macaques.  304:125-134. 2002

The structure of P4 procapsids produced by coexpression of capsid and external scaffolding proteins.  298:224-231. 2002

Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in mice.  296:117-124. 2002

The crystal structure of the influenza matrix protein M1 at neutral pH: M1-M1 protein: Interfaces can rotate in the oligomeric structures of M1.  289:34-44. 2001

T cell apoptosis causes peripheral T cell depletion in mice transgenic for the HIV-1 vpr gene.  285:181-192. 2001

In Vitro exposure to highly cytopathic HIV-1 X4 strains increases expression of mucosa-associated integrins on CD4⁺ T Cells.  280:262-272. 2001

Persistent elevated expression of cytokine transcripts in ganglia latently infected with herpes simplex virus in the absence of ganglionic replication or reactivation.  278:207-216. 2000

Induction of apoptosis by the Vpr protein of human immunodeficiency virus type 1 occurs independently of G2 arrest of the cell cycle.  276:16-26. 2000

In vitro assembly of bacteriophage P4 procapsids from purified capsid and scaffolding proteins.  275:133-144. 2000

The RNA encompassing the internal ribosome entry site in the poliovirus 5' nontranslated region enhances the encapsidation of genomic RNA.  273:391-399. 2000

Neutralization and enhancement of HIV-1 infection by sera from HIV-1 infected individuals who progress to disease at different rates.  273:52-59. 2000

A carboxy-terminally truncated form of the Vpr protein of human immunodeficiency virus type 1 retards cell proliferation independently of G2 arrest of the cell cycle.  263:313-322. 1999

Identification of a human immunodeficiency virus type 1 that stably uses tRNA(Lys1,2) rather than tRNA(Lys,3) for initiation of reverse transcription.  257:95-105. 1999

Cellular proteins bind to the poly(U) tract of the 3' untranslated region of hepatitis C virus RNA genome.  256:105-118. 1999

Complementarity between 3' terminal nucleotides of tRNA and primer binding site is a major determinant for selection of the tRNA primer used for initiation of HIV-1 reverse transcription.  254:160-168. 1999

Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8⁺ cytotoxic T lymphocyte responses induced in mucosa-associated tissues.  254:50-60. 1999

A distal element in the HPV-11 upstream regulatory region contributes to promoter repression in basal keratinocytes in squamous epithelium.  253:219-229. 1999

Electrostatic interactions drive scaffolding/coat protein binding and procapsid maturation in bacteriophage P22.  250:337-349. 1998

Demonstration of the specificity of poliovirus encapsidation using a novel replicon which encodes enzymatically active firefly luciferase.  243:1-11. 1998

Expression, purification, and characterization of a soluble form of human cytomegalovirus glycoprotein B.  239:198-205. 1997

Insights into the interaction between tRNA and primer binding site from characterization of a unique HIV-1 virus which stably maintains dual PBS complementary to tRNA(Gly) and tRNA(His).  238:273-282. 1997

Hemagglutinin specificity and neuraminidase coding capacity of neuraminidase-deficient influenza viruses.  229:155-165. 1997

Nucleotide sequences within the U5 region of the viral RNA genome are the major determinants for an human immunodeficiency virus type 1 to maintain a primer binding site complementary to tRNA(His).  226:306-317. 1996

Characterization of a hemagglutinin-specific inhibitor of influenza A virus.  226:66-76. 1996

Mutations in both the U5 region and the primer-binding site influence the selection of the tRNA used for the initiation of HIV-1 reverse transcription.  222:401-414. 1996

Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells.  222:293-296. 1996

Mutations within the primer binding site of the human immunodeficiency virus type 1 define sequence requirements essential for reverse transcription.  220:290-298. 1996

Poliovirus replicons that express the gag or the envelope surface protein of simian immunodeficiency virus SIVsmm PBj 14.  219:140-149. 1996

Proteolytic activity of human immunodeficiency virus Vpr-and Vpx-protease fusion proteins.  219:307-313. 1996

Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures.  216:133-145. 1996

Molecular Basis for the Resistance of Influenza Viruses to 4-Guanidino-Neu5Ac2en.  214:642-646. 1995

Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1.  212:102-110. 1995

Proteolytic processing of human cytomegalovirus glycoprotein B (gpUL55) is mediatedby the human endoprotease furin.  206:746-749. 1995

Bacteriophage P2 and P4 morphogenesis: Assembly precedes proteolytic processing of the capsid proteins.  205:51-65. 1994

Bacteriophage P2 and P4 assembly: Alternative scaffolding proteins regulate capsid size.  200:702-714. 1994

Sequence analysis and expression of the murine cytomegalovirus phosphoprotein pp50, a homolog of the human cytomegalovirus UL44 gene product.  200:413-427. 1994

Codominant mixtures of viruses in reference strains of influenza virus due to host cell variation.  199:89-97. 1994

Mutations in the Poliovirus P1 Capsid Precursor at Arginine Residues VP4-ARG34, VP3ARG223, and VP1-ARG129 Affect Virus Assembly and Encapsidation of Genomic RNA.  199:20-34. 1994

A cell line that expresses a reporter gene in response to infection by Sindbis virus: A prototype for detection of positive strand RNA viruses.  198:381-384. 1994

Identification of an abundant disulfide-linked complex of glycoproteins in the envelope of guinea pig cytomegalovirus.  201:294-302. 1994

Analysis of Proteins Encoded by IE Regions 1 and 2 of Human Cytomegalovirus Using Monoclonal Antibodies Generated against Recombinant Antigens.  193:642-652. 1993

A Molecular Clone of HIV-1 Tropic and Cytopathic for Human and Chimpanzee Lymphocytes.  194:858-864. 1993

Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.  192:605-617. 1993

Capsid localization of the bacteriophage p4 psu protein.  194:682-687. 1993

Characterization of the capsid associating activity of bacteriophage p4’s psu protein.  194:674-681. 1993

Demonstration of circularization of herpes simplex virus DNA following infection using pulsed field gel electrophoresis.  197:459-462. 1993

Influence of host cell-mediated variation on the international surveillance of influenza a (h3n2) viruses.  196:130-137. 1993

Inhibition of Human Neurotropic Virus (JCV) DNA Replication in Glial Cells by Camptothecin.  196:612-618. 1993

Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components.  193:222-233. 1993

Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.  194:843-850. 1993

Properties of bovine papillomavirus E1 mutants.  191:964-967. 1992

A pilot protein participates in the initiation of P22 procapsid assembly.  182:673-681. 1991

Apical expression of herpes simplex virus type 2 glycoproteins in human neuroblastoma cells.  185:908-910. 1991

Characterization of a membrane-associated phosphoprotein of murine cytomegalovirus (pp50) and its immunological cross-reactivity with a human cytomegalovirus protein.  183:181-194. 1991

Human immunodeficiency virus type 2 vpx protein augments viral infectivity.  184:197-209. 1991

Antiviral effects of apolipoprotein A-I and its synthetic amphipathic peptide analogs.  176:48-57. 1990

Complementation of a vesicular stomatitis virus glycoprotein G mutant with wild-type protein expressed from either a bovine papilloma virus or a vaccinia virus vector system.  178:373-383. 1990

Nuclear compartmentation of glycoprotein B of human cytomegalovirus.  177:515-522. 1990

Characterization of an HPV type 11 isolate propagated in human foreskin implants in nude mice.  171:294-297. 1989

Characterization of cDNAs of spliced HPV-11 E2 mRNA and other HPV mRNAs recovered via retrovirus-mediated gene transfer.  172:468-477. 1989

Characterization of rare human papillomavirus type 11 mRNAs coding for regulatory and structural proteins, using the polymerase chain reaction.  172:489-497. 1989

Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes.  172:331-340. 1989

Extensive heterogeneity in the hemagglutinin of egg-grown influenza viruses from different patients.  171:275-279. 1989

Papillomavirus-associated inductions of cellular proteins in mouse C127 cells: Correlation with the presence of open reading frame E2.  172:170-179. 1989

Antigenic and structural characterization of multiple subpopulations of H3N2 influenza virus from an individual.  165:446-456. 1988

A human papilloma virus type 11 transcript encoding an E1^E4 protein.  159:433-439. 1987

Host cell-mediated variation in H3N2 influenza viruses.  156:386-395. 1987

Studies on herpes simplex virus type 1 glycoproteins using monoclonal antibodies.  151:385-389. 1986

Neutralizing antibodies detect a disulfide-linked glycoprotein complex within the envelope of human cytomegalovirus.  135:369-378. 1984

An immunological focus assay for murine leukemia viruses on viable attached cell lines.  129:212-217. 1983

Characterization of monoclonal antibodies reactive with murine leukemia viruses: Use in analysis of strains of friend MCF and friend ecotropic murine leukemia virus.  127:134-148. 1983

Characterization of mouse monoclonal antibodies specific for friend murine leukemia virus-induced erythroleukemia cells: Friend-specific and FMR-specific antigens.  112:131-144. 1981

Purification and characterization of proteins excreted by cells infected with herpes simplex virus and their use in diagnosis.  91:234-242. 1978

The invertible DNA segments of coliphages Mu and P1 are identical.  74:242-248. 1976